AbbVie

Open: 146.16 Close: 144.73 Change: -1.43

Our AI found some flaws in AbbVie Company Inc Stock.

This document will help you to evaluate AbbVie without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, company, October, Abbvie, report, Inc, Friday, and the …

Concept Map

Semantic Network

Stock Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.

Today's Summary

AbbVie (ABBV) closed at $144.73, marking a -1.03% move from the previous day. The company currently carries a Zacks Rank #3. Abbvie recast historically reported LINZESS U.S. net sales.

Today's News

AbbVie is a global, research-based biopharmaceutical company formed in 2013. AbbVie will announce its third-quarter 2023 financial results on Friday, October 27, 2023. The company will host a live webcast of the earnings conference call. AbbVie (ABBV) closed at $144.73, marking a -1.03% move from the previous day. The company currently carries a Zacks Rank #3. AbbVie to Host Third-Quarter 2023 Earnings Conference Call 10/4/2023 Abbvie to host conference call on October 27, 2023. AbbVie (NYSE:ABBV) is in the Health Care sector and Biotechnology industry. Q3 earnings are confirmed for Friday, October 27, 2023. There is no upcoming split. AbbVie designed for iPhone Designed for iPhone Free iPhone Screenshots. Use this app to participant in an Allergan/Abbvie clinical study. Todays Research Daily features new research reports on 16 major stocks, including Visa Inc., AbbVie Inc. V, Abbvie and BHP. Visa has gained +8.7% over the past year against the Zacks Large Cap Pharmaceuticals industrys gain of +27.8%. AbbVie Inc. (ABBV) Last Closing Price: 144.73 (2023-10-23) Last closing Price:144.73. Is Abbvie A Buy Over The Next 30 Days? Will AbbBVie Soar or Crash? Youve successfully subscribed, thank you! AbbVie recast historically reported LINZESS U.S. net sales (previously reported by Allergan) for periods between January 1, 2019 and March 30, 2020, to conform to Abbvies revenue recognition accounting policies.

Stock Profile

"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."

Keywords

The game is changing. There is a new strategy to evaluate AbbVie fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, company, October, Abbvie, report, Inc, Friday, and the most common words in the summary are: abbvie, stock, market, job, inc, news, abbv, . One of the sentences in the summary was: net sales.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbvie #stock #market #job #inc #news #abbv.